Clinical Trials Logo

Clinical Trial Summary

The severe sepsis (SS) and toxic shock (TS) are both frequent and severe complications of infectious diseases. They are one of the top ten causes of death in industrialized countries. But an eventual protective role of beta-blockers (anti-hypertensive drug) in their occurrence on a community infection has never been studied. The objective of this study is to evaluate this role.


Clinical Trial Description

The severe sepsis (SS) and toxic shock (TS) are both frequent and severe complications of infectious diseases. They are one of the top ten causes of death in industrialized countries. The adrenergic system is heavily involved in this pathological/physiological context. If the effect of various therapeutic strategies allowing the care of the SS/TS was widely estimated, the impact, positive or negative, therapeutic prescribed in the long term or more punctually - but be that as it may before the arisen of the sepsis - on the evolution of a community acute infectious pathology towards the SS/TS, had only little studied.

The main objective of this study is to estimate the possible protective role of a long-term prescription of a beta-blocker on the arisen of the SS/TS in patients having an acute infectious pathology of community origin.

The secondary objective will be to estimate, at the patients having developed a SS/TS, the impact of this long-term prescription of beta-blockers on the mortality in intensive care unit (ICU). ;


Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01606631
Study type Observational
Source Rennes University Hospital
Contact
Status Completed
Phase N/A
Start date September 2009
Completion date February 2012

See also
  Status Clinical Trial Phase
Completed NCT02946775 - Community Acquired Bacteremic Syndromes in Young Nigerian Children
Completed NCT03655548 - Optimization Management Study of Community Urinary Tract Infections Spectrum
Completed NCT02531438 - Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13) Phase 3
Completed NCT00575094 - Study Evaluating the Safety and Efficacy of Intravenous Tigecycline to Treat Hospitalized Japanese Subjects Phase 3
Recruiting NCT05047549 - Community-based RSV Surveillance in Infant Mortality: Minimally Invasive Tissue Sampling Study in Karachi, Pakistan
Completed NCT04348734 - Management of Parapneumonic Pleurisy Guided by an Early Pleural Ultrasound
Completed NCT00475930 - Chlorhexidine Impregnated Cloths to Prevent Skin and Soft Tissue Infections in Marine Officer Candidates N/A
Enrolling by invitation NCT03924934 - Community-associated Highly-Resistant Enterobacterales
Recruiting NCT03093220 - Molecular Typing of Community-acquired Pneumonia Based on Multiple-omic Data Analysis N/A
Not yet recruiting NCT03185923 - Effect of Traditional Chinese Medicine on Outcomes in Patients With Severe Pneumonia Phase 3
Not yet recruiting NCT06103500 - Integrated Clinical Decision Support for Empiric Antibiotic Selection in Sepsis N/A
Completed NCT01563315 - Community-acquired Pneumonia in Buskerud County in Norway N/A
Terminated NCT00603564 - Helmet Continuous Positive Airway Pressure Versus Oxygen Venturi in Acute Respiratory Failure in CAP: CAPOVeRSO N/A
Completed NCT00081575 - Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia Phase 3
Completed NCT01396798 - Validation of Vital Signs and Symptoms for the Diagnosis of Serious Infections in Children in the Paediatric A&E. N/A
Recruiting NCT03379402 - Sepsis-3 Study in Northeast Thailand
Terminated NCT01110421 - A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia Phase 3
Recruiting NCT03064464 - CA-MRSA Infection in China: Epidemiology, Molecular Characteristics, Treatment, and Outcome N/A